APA (7th ed.) Citation

Y, Z., OG, B., KS, C., R, W., & N, Y. (2026). Use of blood-based neurofilament light chain as an endpoint in clinical trials of neurodegenerative conditions: A scoping review. Journal of neurology, 273(8), . https://doi.org/10.1007/s00415-026-14007-5

Chicago Style (17th ed.) Citation

Y, Zheng, Bhalala OG, Chin KS, Watson R, and Yassi N. "Use of Blood-based Neurofilament Light Chain as an Endpoint in Clinical Trials of Neurodegenerative Conditions: A Scoping Review." Journal of Neurology 273, no. 8 (2026). https://doi.org/10.1007/s00415-026-14007-5.

MLA (9th ed.) Citation

Y, Zheng, et al. "Use of Blood-based Neurofilament Light Chain as an Endpoint in Clinical Trials of Neurodegenerative Conditions: A Scoping Review." Journal of Neurology, vol. 273, no. 8, 2026, https://doi.org/10.1007/s00415-026-14007-5.